New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients
Yu Kyong Kim,1 Anhye Kim,1,2 Shin Jung Park,3 Howard Lee1,4 1Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, 2Clinical Trial Center, Ajou University Medical Center, Suwon, 3Research Institute, Chong Kun Dang Pharmaceutical Corp...
Saved in:
Main Authors: | Kim YK (Author), Kim A (Author), Park SJ (Author), Lee H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of a novel tablet formulation of tacrolimus and conventional capsule formulation in de novo kidney transplant recipients: a systematic review and meta-analysis
by: Zhenyu Liu, et al.
Published: (2023) -
The Lidose Hard Capsule Formulation of Fenofibrate is Suprabioavailable Compared to the Nanoparticle Tablet Formulation Under High-fat Fed Conditions
by: Roger K Verbeeck, et al.
Published: (2015) -
Formulation and bioequivalence studies of choline alfoscerate tablet comparing with soft gelatin capsule in healthy male volunteers
by: Min MH, et al.
Published: (2019) -
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
by: Pere Fontova, et al.
Published: (2023) -
Determination of tacrolimus in pharmaceutical formulations by validated spectrophotometric methods
by: T.M. Böer, et al.
Published: (2008)